GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » KPC Pharmaceuticals Inc (SHSE:600422) » Definitions » Market Cap

KPC Pharmaceuticals (SHSE:600422) Market Cap : ¥13,323 Mil (As of Apr. 23, 2025)


View and export this data going back to 2000. Start your Free Trial

What is KPC Pharmaceuticals Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). KPC Pharmaceuticals's share price for the quarter that ended in Dec. 2024 was ¥15.85. KPC Pharmaceuticals's Shares Outstanding (EOP) for the quarter that ended in Dec. 2024 was 757 Mil. Therefore, KPC Pharmaceuticals's market cap for the quarter that ended in Dec. 2024 was ¥11,998 Mil.

KPC Pharmaceuticals's quarterly market cap declined from Jun. 2024 (¥13,499 Mil) to Sep. 2024 (¥11,990 Mil) but then increased from Sep. 2024 (¥11,990 Mil) to Dec. 2024 (¥11,998 Mil).

KPC Pharmaceuticals's annual market cap increased from Dec. 2022 (¥10,707 Mil) to Dec. 2023 (¥15,812 Mil) but then declined from Dec. 2023 (¥15,812 Mil) to Dec. 2024 (¥11,998 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. KPC Pharmaceuticals's Enterprise Value for Today is ¥12,858 Mil.


KPC Pharmaceuticals Market Cap Historical Data

The historical data trend for KPC Pharmaceuticals's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

KPC Pharmaceuticals Market Cap Chart

KPC Pharmaceuticals Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6,558.91 8,378.73 10,706.57 15,811.61 11,998.07

KPC Pharmaceuticals Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15,811.61 16,285.52 13,499.34 11,990.50 11,998.07

Competitive Comparison of KPC Pharmaceuticals's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, KPC Pharmaceuticals's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


KPC Pharmaceuticals's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, KPC Pharmaceuticals's Market Cap distribution charts can be found below:

* The bar in red indicates where KPC Pharmaceuticals's Market Cap falls into.


;
;

KPC Pharmaceuticals Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

KPC Pharmaceuticals's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as

Market Cap (A: Dec. 2024 )=Share Price (A: Dec. 2024 )*Shares Outstanding (EOP) (A: Dec. 2024 )
=¥15.85*756.976
=¥11,998

KPC Pharmaceuticals's Market Cap for the quarter that ended in Dec. 2024 is calculated as

Market Cap (Q: Dec. 2024 )=Share Price (Q: Dec. 2024 )*Shares Outstanding (EOP) (Q: Dec. 2024 )
=¥15.85*756.976
=¥11,998

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


KPC Pharmaceuticals  (SHSE:600422) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


KPC Pharmaceuticals Market Cap Related Terms

Thank you for viewing the detailed overview of KPC Pharmaceuticals's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


KPC Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
No. 166 Keyi Road, State New and High-Technology Development Zone, Kunming, Yunnan, CHN, 650106
KPC Pharmaceuticals Inc is a pharmaceutical company which focused on innovative natural botanical drugs in China. Its business scope covers traditional Chinese medicine, chemical medicine, and medicinal circulation. Its products include Panax notoginseng, gastrodine, artemether, and special botanical drugs.
Executives
Qu Xiao Ru senior management
Xie Bo senior management
Meng Li senior management
Zhong Xiang Gang senior management
Wu Sheng Long senior management
Liu Jun Feng senior management
Wang Lei senior management
Zhang Meng Xun senior management
Hu Zhen Bo senior management
Sun Lei senior management
Xu Chao Neng senior management
Wang Jun senior management
Zhao Jian senior management
He Qin Director
Dai Xiao Chang senior management

KPC Pharmaceuticals Headlines

No Headlines